Advancing Research with Mouse Models
The Preclinical Modeling shared resource at Fred Hutch supports the development and maintenance of preclinical mouse models, including patient-derived xenografts (PDX), cell-line xenografts and genetically engineered mouse models (GEMM). We work with investigators in the Fred Hutch/University of Washington Cancer Consortium and other institutions to enable preclinical research on cancer and other diseases.
World-Class PDX Services
Our PDX experts have created xenograft models of dozens of cancers, including Merkel cell carcinoma and cancers of the liver, bladder, lung and pancreas, on behalf of investigators across Seattle and beyond. The NSG breeding colony Comparative Medicine maintains guarantees mice are always available for PDX implants, and we’ve performed more than 2,000 xenograft surgeries since 2016.
Cutting-Edge Genome Engineering
Our GEMM team designs, produces and maintains transgenic and gene-edited mice in partnership with investigators pursuing a variety of research questions. Our high editing efficiency — up to 100% of live-born pups in our projects exhibit successful gene targeting — is testament to our expertise in CRISPR/Cas9 and other state-of-the-art genome engineering technologies.
Our Team at Work
The comprehensive, specialized services provided to investigators by the experts on our PDX and GEMM teams begin with experimental consultation, followed by sourcing, generation or resuscitation of models, animal care, regulatory support, dosing and sample collection support, tissue banking and more.
GEMM technician performs mouse pronuclear microinjections.
Lab technician works in the PDX lab in the PMCL Shared Resource.
PDX technician Sarah Masunaga and her colleagues offer comprehensive services in preclinical xenograft models.
GEMM technician performs mouse pronuclear microinjections.
Lab technician works in the PDX lab in the PMCL Shared Resource.
PDX technician Sarah Masunaga and her colleagues offer comprehensive services in preclinical xenograft models.
40+
60+
8
>85
How to Reach Us
Gordon Roble, DVM, MBA
